Iconovo
1.12 SEK
-2.61 %
Less than 1K followers
ICO
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-2.61 %
-28.89 %
-49.78 %
-34.12 %
-70.12 %
-70.96 %
-97.50 %
-97.42 %
-96.56 %
Iconovo operates in the medical technology sector. The company develops inhalers for medical use. The company's products are used in the treatment of asthma and coal, where the inhalers consist of powder-based medicine. The products are licensed and sold under various brands. In addition to product development, there is expertise in pharmaceutical formulation. The company was founded in 2013 and has its headquarters in Lund.
Read moreMarket cap
83.78M SEK
Turnover
224.76K SEK
Revenue
2.93M
EBIT %
-1,402.05 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Iconovo announces that the terms and conditions for allotment of shares in directed issue are met
Kommuniké från extra bolagsstämma i Iconovo AB den 15 december 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools